Kewaunee Scientific Corporation reported earnings results for the fourth quarter and full year ended April 30, 2022. For the fourth quarter, the company reported sales was USD 49.72 million compared to USD 38.71 million a year ago. Net loss was USD 0.362 million compared to USD 2.98 million a year ago. Basic loss per share from continuing operations was USD 0.13 compared to USD 1.08 a year ago. Diluted loss per share from continuing operations was USD 0.13 compared to USD 1.08 a year ago.
For the full year, sales was USD 168.87 million compared to USD 147.47 million a year ago. Net loss was USD 6.13 million compared to USD 3.67 million a year ago. Basic loss per share from continuing operations was USD 2.2 compared to USD 1.33 a year ago. Diluted loss per share from continuing operations was USD 2.2 compared to USD 1.33 a year ago.